28th September, 2016
Daniel Barton spoke with Fintan Walton of Pharmaventures about the Biosceptre portfolio while attending the Sachs Associates 16th Annual Biotech in Europe Conference in Basel Switzerland.
For privacy reasons YouTube needs your permission to be loaded. For more details, please see our Privacy Policy.
I Accept